Study Name:
RItuximab for lupus Nephritis with remission as a Goal, an investigator-initiated randomized international open multicentric study (RING study)

Phase:
Phase 3 Clinical Trial

EudraCT number:
2012-000314-13

National Investigator Coordinator:
Prof. Dr. Carlos Vasconcelos (Centro Hospitalar do Porto)

Sponsor:
Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Bruxelas

Participating countries:
Argentina, Austria, Belgium, Brazil, Colombia, Spain, France, Greece, The Netherlands, Italy, Japan, Morocco, Norway, United Kingdom, Czech Republic, Romania, Russia, Sweden, Switzerland, Turkey

Sites in Portugal:
Centro Hospitalar do Porto, Centro Hospitalar Lisboa Central – Hospital Curry Cabral, Centro Hospitalar Universitário de Coimbra

Status:
Finished